- Stocks
- Healthcare
- NASDAQ: GOVX

Price (delayed)

$4.37

Market cap

$27.6M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.34

Enterprise value

$6.95M

The equity has surged by 116% since the previous quarter

The EPS has dropped by 100% year-on-year but it has soared by 84% since the previous quarter

GeoVax Labs's net income has plunged by 73% YoY and by 33% from the previous quarter

The company's gross profit fell by 33% QoQ and by 20% YoY

What are the main financial stats of GOVX

Market
Valuations
Earnings

Shares outstanding

6.32M

Market cap

$27.6M

Enterprise value

$6.95M

Price to earnings (P/E)

N/A

Price to book (P/B)

1.34

Price to sales (P/S)

19.13

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

5.7

Revenue

$1.22M

EBIT

-$3.78M

EBITDA

-$3.76M

Free cash flow

-$4.17M

Per share
Balance sheet
Liquidity

EPS

-$0.34

Free cash flow per share

-$0.78

Book value per share

$3.27

Revenue per share

$0.23

TBVPS

$3.96

Total assets

$21.12M

Total liabilities

$464,106

Debt

$195,001

Equity

$20.65M

Working capital

$20.51M

Debt to equity

0.01

Current ratio

46.38

Quick ratio

46.14

Net debt/EBITDA

5.5

Margins
Efficiency
Dividend

EBITDA margin

-308.6%

Gross margin

100%

Net margin

-322.2%

Operating margin

-310.8%

Return on assets

-35.5%

Return on equity

-40.1%

Return on invested capital

N/A

Return on capital employed

-18.3%

Return on sales

-310.5%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the GeoVax Labs stock price performed over time

Intraday

3.55%

1 week

-5.82%

1 month

-8%

1 year

9.25%

YTD

29.29%

QTD

-12.6%

How have GeoVax Labs's revenue and profit performed over time

Revenue

$1.22M

Gross profit

$1.22M

Operating income

-$3.79M

Net income

-$3.93M

Gross margin

100%

Net margin

-322.2%

The net margin has dropped by 117% year-on-year and by 99% since the previous quarter

GOVX's operating margin has dropped by 110% year-on-year and by 101% since the previous quarter

GeoVax Labs's net income has plunged by 73% YoY and by 33% from the previous quarter

The operating income has plunged by 67% YoY and by 34% from the previous quarter

What is GeoVax Labs's growth rate over time

What is GeoVax Labs stock price valuation

P/E

N/A

P/B

1.34

P/S

19.13

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

5.7

The EPS has dropped by 100% year-on-year but it has soared by 84% since the previous quarter

The equity has surged by 116% since the previous quarter

The P/S is 91% below the 5-year quarterly average of 214.2 and 33% below the last 4 quarters average of 27.4

GeoVax Labs's revenue has decreased by 33% QoQ and by 20% YoY

How efficient is GeoVax Labs business performance

The ROS has dropped by 110% year-on-year and by 101% since the previous quarter

The ROA has soared by 90% year-on-year and by 28% since the previous quarter

The return on equity rose by 44% since the previous quarter

What is GOVX's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for GOVX.

How did GeoVax Labs financials performed over time

GOVX's total assets has soared by 103% from the previous quarter

GOVX's total liabilities has dropped by 83% year-on-year and by 44% since the previous quarter

The debt is 99% smaller than the equity

The debt to equity has soared by 150% year-on-year but it has dropped by 50% since the previous quarter

The equity has surged by 116% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.